<VariationArchive VariationID="970762" VariationName="NM_000397.4(CYBB):c.141+1del" VariationType="Deletion" Accession="VCV000970762" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="959284" VariationID="970762">
      <GeneList>
        <Gene Symbol="CYBB" FullName="cytochrome b-245 beta chain" GeneID="1536" HGNC_ID="HGNC:2578" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.1-11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37780059" stop="37813461" display_start="37780059" display_stop="37813461" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37639269" stop="37672713" display_start="37639269" display_stop="37672713" Strand="+" />
          </Location>
          <OMIM>300481</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000397.4(CYBB):c.141+1del</Name>
      <CanonicalSPDI>NC_000023.11:37782180:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37782181" stop="37782181" display_start="37782181" display_stop="37782181" variantLength="1" positionVCF="37782180" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37641434" stop="37641434" display_start="37641434" display_stop="37641434" variantLength="1" positionVCF="37641433" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.37641437del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.37641437del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.37782184del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.37782184del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009065.1" sequenceAccession="NG_009065" sequenceVersion="1" change="g.7168del">
            <Expression>NG_009065.1:g.7168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000397.4" sequenceAccession="NM_000397" sequenceVersion="4" change="c.141+1del" MANESelect="true">
            <Expression>NM_000397.4:c.141+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_53" sequenceAccession="LRG_53">
            <Expression>LRG_53:g.7168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_53t1" sequenceAccession="LRG_53t1">
            <Expression>LRG_53t1:c.141del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1928965951" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000397.4(CYBB):c.141+1del AND Granulomatous disease, chronic, X-linked" Accession="RCV001246396" Version="6">
        <ClassifiedConditionList TraitSetID="3042">
          <ClassifiedCondition DB="MedGen" ID="C1844376">Granulomatous disease, chronic, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20729109</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8634410</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9585602</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3042" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1398" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC</ElementValue>
                <XRef Type="Allelic variant" ID="300481.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, X-linked</ElementValue>
                <XRef ID="MONDO:0010600" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">X-CGD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CGDX</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CGD</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15294" />
                <XRef ID="15294" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1844376" DB="MedGen" />
              <XRef ID="MONDO:0010600" DB="MONDO" />
              <XRef Type="MIM" ID="306400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2754865" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4968903|MedGen:C1844376" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001419746" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9585602</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20729109</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8634410</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in CYBB are known to be pathogenic (PMID: 9585602, 20729109). This variant has been observed in an individual affected with clinical features of chronic granulomatous disease (PMID: 8634410). This variant may also be known as c.151del, c.152del, c.153del, or c.153+1del in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ser48Glnfs*13) in the CYBB gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.37641434del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1844376" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2754865" TraitType="Disease" MappingType="XRef" MappingValue="C1844376" MappingRef="MedGen">
        <MedGen CUI="C1844376" Name="Granulomatous disease, chronic, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

